FDA Clinical Site Inspections Should Look At Recruitment Tactics - IG Report
This article was originally published in The Tan Sheet
Executive Summary
FDA clinical site inspections should focus on recruitment tactics as well as data integrity, the HHS Office of the Inspector General suggests in a report on clinical trial recruitment released June 12.